Variations in the pathology of atrophic gastritis have been reported to some degree in genetically engineered mice such as Atp4a−/− and gastrin−/− mice, which are used as models of parietal and glandular cell loss. This evidence concerns the gene GAST and chronic atrophic gastritis.